Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors
Authors:
- Stéphane RaeppelSRStéphane Raeppel
- Soon H. WooSWSoon H. Woo
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (3) , 1067-1071
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- VorinostatNature Reviews Drug Discovery, 2007
- Rational Design of Non-Hydroxamate Histone Deacetylase InhibitorsMini-Reviews in Medicinal Chemistry, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- Non-hydroxamate Histone Deacetylase InhibitorsCurrent Medicinal Chemistry, 2005
- Histone Deacetylase Inhibitors: Latest Developments, Trends and ProspectsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- Histone deacetylase inhibitorsEuropean Journal of Medicinal Chemistry, 2005
- Patent status of histone deacetylase inhibitorsExpert Opinion on Therapeutic Patents, 2004
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Translating the Histone CodeScience, 2001
- Histone Deacetylase: A Target for Antiproliferative and Antiprotozoal AgentsCurrent Medicinal Chemistry, 2001